Standard BioTools Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $3.04 on 04/09/24 and a low of $1.17 for the same time frame on 02/26/25.
52-week price history of LAB Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Standard BioTools Inc’s current trading price is -61.51% away from its 52-week high, while its distance from the 52-week low is -0.21%. The stock’s price range during this period has spanned from $1.17 to $3.04. In the Healthcare sector, the Standard BioTools Inc’s shares surpassed a trading volume of approximately 3.16 million for the day, which was noticeably higher compared to the average daily volume of 9.1.67 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Standard BioTools Inc (LAB) has experienced a quarterly decline of -27.78% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 435.55M and boasts a workforce of 539 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.7554, with a change in price of -0.6900. Similarly, Standard BioTools Inc recorded 1,812,952 in trading volume during the last 100 days, posting a change of -37.10%.
Examining LAB’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for LAB stands at 0.18. Similarly, the long-term debt-to-equity ratio is also 0.06.
LAB Stock Stochastic Average
Today, Standard BioTools Inc’s raw stochastic average for the past 50 days stands at 1.37%, indicating a decline from the raw stochastic average of the last 20 days, which was 2.94%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 17.07% and 23.18% respectively.
LAB Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded a decrease of -33.14%. However, over the last six months, the performance has been stronger by -45.33%. The price of LAB decreased -25.48% over the last 30 days. And in the last five days, it has fallen by -15.83%.
